More biotechs announce share buybacks; Cosette to buy Mayne Pharma

Plus, news about MeiraGTx, Hookipa and Poolbeg Pharma:

A pair of $500M share buybacks: Exelixis and

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Transforming Shots Into Pills; ‘Tip of the Iceberg’ for TILs? Food Additives Warning

A California startup has the lofty goal of transforming blockbuster injectable and infusional drugs into pills. (Endpoints News) Johnson & Johnson announced FDA approval of

February 24, 2024

JP Morgan 2025: Moderna stock suffers after CEO reveals conservative 2025 guidance – Pharmaceutical Technology

Moderna share price took a blow as CEO Stéphane Bancel outlined a diminished guidance for 2025. Credit: Boston Globe/ Getty Images Moderna lost more than

January 14, 2025

Proposed PFAS rule would cost companies estimated $1B; lacks limits and cleanup requirement

A proposed federal rule calls for forcing companies to disclose whether their products contain toxic “forever” chemicals, the government’s first attempt at cataloging the pervasiveness

July 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.